35,631 Shares in Envista Holdings Co. (NYSE:NVST) Acquired by XTX Topco Ltd

XTX Topco Ltd bought a new stake in Envista Holdings Co. (NYSE:NVST - Free Report) during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 35,631 shares of the company's stock, valued at approximately $704,000.

Other large investors also recently made changes to their positions in the company. Villanova Investment Management Co LLC bought a new position in Envista during the third quarter worth about $1,066,000. Readystate Asset Management LP grew its position in shares of Envista by 16.7% during the 3rd quarter. Readystate Asset Management LP now owns 51,016 shares of the company's stock worth $1,008,000 after purchasing an additional 7,288 shares in the last quarter. Point72 Asset Management L.P. bought a new position in shares of Envista during the third quarter worth approximately $37,559,000. Polar Asset Management Partners Inc. raised its position in shares of Envista by 375.6% in the third quarter. Polar Asset Management Partners Inc. now owns 1,497,250 shares of the company's stock valued at $29,586,000 after buying an additional 1,182,450 shares in the last quarter. Finally, Iron Triangle Partners LP bought a new stake in shares of Envista in the third quarter valued at approximately $43,262,000.

Analyst Upgrades and Downgrades

Several equities analysts have weighed in on NVST shares. Mizuho assumed coverage on Envista in a report on Wednesday, December 4th. They issued an "underperform" rating and a $20.00 price objective for the company. Robert W. Baird upped their price objective on shares of Envista from $17.00 to $22.00 and gave the stock a "neutral" rating in a research report on Thursday, October 31st. Leerink Partners upgraded shares of Envista from an "underperform" rating to a "market perform" rating and increased their price objective for the stock from $16.00 to $23.00 in a research note on Thursday, October 31st. Stifel Nicolaus boosted their target price on shares of Envista from $18.00 to $21.00 and gave the company a "buy" rating in a research report on Wednesday, October 23rd. Finally, Needham & Company LLC reiterated a "hold" rating on shares of Envista in a research report on Thursday, October 31st. Two research analysts have rated the stock with a sell rating, eleven have given a hold rating and three have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and an average price target of $20.65.

Envista Trading Down 1.1 %

Envista stock traded down $0.22 during trading hours on Thursday, reaching $20.30. 1,523,622 shares of the company's stock were exchanged, compared to its average volume of 2,369,990. The firm has a market capitalization of $3.49 billion, a PE ratio of -2.64, a PEG ratio of 2.77 and a beta of 1.31. The company has a quick ratio of 1.77, a current ratio of 2.08 and a debt-to-equity ratio of 0.42. The firm's 50 day simple moving average is $20.03 and its 200 day simple moving average is $18.41. Envista Holdings Co. has a twelve month low of $15.15 and a twelve month high of $25.64.

Envista (NYSE:NVST - Get Free Report) last issued its earnings results on Wednesday, October 30th. The company reported $0.12 earnings per share for the quarter, topping analysts' consensus estimates of $0.09 by $0.03. The business had revenue of $601.00 million during the quarter, compared to the consensus estimate of $590.34 million. Envista had a positive return on equity of 3.76% and a negative net margin of 53.42%. The firm's revenue for the quarter was down 4.8% on a year-over-year basis. During the same period in the previous year, the company posted $0.43 earnings per share. Research analysts predict that Envista Holdings Co. will post 0.72 earnings per share for the current year.

About Envista

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.